The bioelectrical properties of pancreatic islet cells: effects of diabetogenic agents.
D000200:Action Potentials; D000496:Alloxan / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D003921:Diabetes Mellitus, Experimental / Q000503:physiopathology; D005260:Female; D005944:Glucosamine / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D005978:Glutathione / Q000494:pharmacology; D005985:Glyceraldehyde / Q000494:pharmacology; D006539:Heptoses / Q000494:pharmacology; D066298:In Vitro Techniques; D007515:Islets of Langerhans / Q000187:drug effects*; D007930:Leucine / Q000494:pharmacology; D008297:Male; D051379:Mice; D009536:Niacinamide / Q000494:pharmacology; D009603:Nitroso Compounds / Q000494:pharmacology*; D014044:Tolbutamide / Q000494:pharmacology; D014508:Urea / Q000494:pharmacology*
D000900:Anti-Bacterial Agents; D006539:Heptoses; D009603:Nitroso Compounds; D009536:Niacinamide; D005985:Glyceraldehyde; D000496:Alloxan; D014508:Urea; D014044:Tolbutamide; D005978:Glutathione; D007930:Leucine; D005947:Glucose; D005944:Glucosamine